Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

CRDF

Cardiff Oncology Inc

Dec 11 • 04:00PM ET

3.70

Dollar change 0.00
Percentage change 0.00	%

Healthcare • Biotechnology • USA • NASD

Peers: BPMC FOLD XNCR NERV AFMD BGNE KPTI CARA ATNM

| Held by: IWM VTI VXF IWN VTWO IWO IWC AVSC RSSL DFAS

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.95	Insider Own	7.06%	Shs Outstand	48.73M	Perf Week	53.53%
Market Cap	189.19M	Forward P/E	-	EPS next Y	-0.98	Insider Trans	0.00%	Shs Float	47.52M	Perf Month	6.94%
Income	-43.01M	PEG	-	EPS next Q	-0.25	Inst Own	24.93%	Short Float	17.21%	Perf Quarter	44.53%
Sales	0.69M	P/S	274.19	EPS this Y	-7.10%	Inst Trans	-2.06%	Short Ratio	5.08	Perf Half Y	25.42%
Book/sh	1.01	P/B	3.65	EPS next Y	1.41%	ROA	-56.80%	Short Interest	8.18M	Perf Year	189.06%
Cash/sh	1.13	P/C	3.28	EPS next 5Y	-	ROE	-67.57%	52W Range	1.25 - 6.42	Perf YTD	150.00%
Dividend Est.	-	P/FCF	-	EPS past 5Y	35.42%	ROI	-85.38%	52W High	-42.37%	Beta	1.90
Dividend TTM	-	Quick Ratio	4.74	Sales past 5Y	9.26%	Gross Margin	40.35%	52W Low	196.00%	ATR (14)	0.36
Dividend Ex-Date	-	Current Ratio	4.74	EPS Y/Y TTM	-3.88%	Oper. Margin	-6735.99%	RSI (14)	67.80	Volatility	13.78% 8.66%
Employees	32	Debt/Eq	0.03	Sales Y/Y TTM	49.78%	Profit Margin	-6241.65%	Recom	1.00	Target Price	9.33
Option/Short	Yes / Yes	LT Debt/Eq	0.02	EPS Q/Q	-16.15%	Payout	-	Rel Volume	0.00	Prev Close	3.70
Sales Surprise	135.71%	EPS Surprise	7.24%	Sales Q/Q	17.02%	Earnings	Nov 07 AMC	Avg Volume	1.61M	Price	3.70
SMA20	38.68%	SMA50	29.83%	SMA200	17.19%	Trades		Volume	0	Change	0.00%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-06-24	Initiated	Craig Hallum	Buy	$8
Jan-05-22	Initiated	William Blair	Outperform
Dec-08-21	Initiated	Robert W. Baird	Outperform	$19
Aug-09-21	Resumed	Maxim Group	Buy	$30 → $20
Oct-22-20	Initiated	H.C. Wainwright	Buy	$27
Oct-08-20	Initiated	Piper Sandler	Overweight	$25

Dec-11-24 07:19AM	Cardiff Oncology Reports Promising Phase 2 Trial Results (TipRanks)
Dec-10-24 07:20AM	Cardiff Oncology Prices Oversubscribed $40 Million Underwritten Registered Direct Offering (GlobeNewswire) +54.92%
06:00AM	Cardiff Oncology Announces Positive Initial Data from First-line RAS-mutated mCRC Clinical Trial (GlobeNewswire)
Nov-19-24 08:00AM	Cardiff Oncology Announces New Patent with Claims for the Use of Onvansertib in Treating KRAS mutated mCRC (GlobeNewswire)
Nov-07-24 04:05PM	Cardiff Oncology Reports Third Quarter 2024 Results and Provides Business Update (GlobeNewswire) +7.35% -24.69%
04:30PM	Loading…
Oct-30-24 04:30PM	Cardiff Oncology Announces Journal of Clinical Oncology Publication of Data from Phase 2 Trial in Second-line KRAS Mutant mCRC (GlobeNewswire)
Aug-08-24 04:05PM	Cardiff Oncology Reports Second Quarter 2024 Results and Provides Business Update (GlobeNewswire) +11.74%
Aug-01-24 04:05PM	Cardiff Oncology to Report Second Quarter 2024 Results and Provide Business Update (GlobeNewswire)
May-29-24 04:05PM	Cardiff Oncology to Present at the Jefferies Healthcare Conference (GlobeNewswire)
May-13-24 04:05PM	Cardiff Oncology to Present at Upcoming Investor Conferences in May (GlobeNewswire)
May-09-24 12:15PM	Fight Against Pancreatic Cancer Ramps Up as Market Size Revenues Expected to Exceed $36 Billion by 2036 (PR Newswire) +5.62%
May-07-24 06:00AM	The $5 Phenoms: 3 Cheap Stocks That Could Skyrocket by 2028 (InvestorPlace)
May-02-24 09:54PM	CRDF Stock Earnings: Cardiff Oncology Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace) +5.91% -21.43%
05:45PM	Cardiff Oncology (CRDF) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Cardiff Oncology Reports First Quarter 2024 Results and Provides Business Update (GlobeNewswire)
04:05PM	Loading…
Apr-25-24 04:05PM	Cardiff Oncology to Report First Quarter 2024 Results and Provide Business Update (GlobeNewswire)
Apr-08-24 04:05PM	Cardiff Oncology Presents Novel Preclinical Data at AACR Annual Meeting 2024 that Supports Ongoing First-line RAS-mutated mCRC Clinical Study (GlobeNewswire)
Apr-01-24 08:50AM	Cardiff Oncology (CRDF) Is a Great Choice for 'Trend' Investors, Here's Why (Zacks) +7.30%
Mar-21-24 07:55AM	Cardiff (CRDF) Stock Rallies 194% in a Month: Here's Why (Zacks)
Mar-14-24 08:50AM	Here's Why Momentum in Cardiff Oncology (CRDF) Should Keep going (Zacks)
08:08AM	Cardiff Oncology (CRDF) Moves 20.5% Higher: Will This Strength Last? (Zacks)
Mar-06-24 04:05PM	Cardiff Oncology Announces Upcoming Presentations at the AACR Annual Meeting 2024 (GlobeNewswire) +6.58% -9.77%
12:00PM	What Makes Cardiff Oncology (CRDF) a Strong Momentum Stock: Buy Now? (Zacks)
Mar-01-24 10:12AM	Cardiff Oncology Inc (CRDF) Reports Q4 and Full Year 2023 Financial Results (GuruFocus.com) +64.87%
Feb-29-24 07:40PM	Cardiff Oncology (CRDF) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:07PM	Cardiff Oncology Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update (GlobeNewswire)
04:06PM	Cardiff Oncology Provides Clinical Update on Phase 2 Randomized Second-line ONSEMBLE Trial in Patients with RAS-mutated mCRC (GlobeNewswire)
04:05PM	Cardiff Oncology Announces First Patient Dosed in Randomized First-line RAS-mutated Metastatic Colorectal Cancer Trial (CRDF-004) (GlobeNewswire)
Feb-26-24 08:00AM	Cardiff Oncology to Present at the Cowen 44th Annual Health Care Conference (GlobeNewswire)
Feb-22-24 08:00AM	Cardiff Oncology to Report Fourth Quarter and Full Year 2023 Results and Provide Business Update (GlobeNewswire)
10:30AM	Loading…
Jan-17-24 10:30AM	Cardiff Oncology Announces Publication of Data from Phase 1b study in second-line KRAS-mutated mCRC in Clinical Cancer Research (PR Newswire) -9.82%
Nov-20-23 04:05PM	Cardiff Oncology to Present at the 35th Annual Piper Sandler Healthcare Conference (PR Newswire)
Nov-02-23 04:05PM	Cardiff Oncology Reports Third Quarter 2023 Results and Provides Business Update (PR Newswire) +8.57%
Oct-26-23 04:05PM	Cardiff Oncology to Report Third Quarter 2023 Financial Results and Provide Business Update (PR Newswire)
Oct-23-23 08:45AM	Rising Number of Studies to Develop Novel Therapies For Pancreatic Ductal Adenocarcinoma (PDAC) Intensely Increasing (PR Newswire) -10.27%
Oct-11-23 09:35AM	Cardiff Oncology (CRDF) Loses -29.75% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner (Zacks)
Sep-26-23 04:05PM	Cardiff Oncology Announces Positive Clinical Data in Pancreatic Cancer and Small Cell Lung Cancer, including Single-Agent Activity from Onvansertib Monotherapy (PR Newswire)
Sep-05-23 08:00AM	Cardiff Oncology to Present at Upcoming Investor Conferences in September (PR Newswire)
Aug-09-23 04:05PM	Cardiff Oncology Reports Second Quarter 2023 Results and Provides Business Update (PR Newswire) -12.39% +8.38%
Aug-07-23 04:05PM	Cardiff Oncology Announces New Lead Program in First-Line Metastatic Colorectal Cancer and Expanded Pfizer Relationship (PR Newswire) -8.19% +38.85%
Jul-24-23 05:09PM	Cardiff Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (PR Newswire)
Jun-20-23 05:22PM	Cardiff Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (PR Newswire)
Jun-05-23 08:00AM	Cardiff Oncology to Present at the Jefferies Healthcare Conference (PR Newswire)
May-04-23 04:10PM	Cardiff Oncology Reports First-Quarter 2023 Results and Provides Business Update (PR Newswire)
Mar-28-23 08:00AM	Cardiff Oncology Announces First Patient Dosed in ONSEMBLE Phase 2 Randomized Trial of Onvansertib in Patients with Metastatic Colorectal Cancer (PR Newswire)
Mar-06-23 08:15AM	Cardiff Oncology Formally Introduces Scientific Advisory Board (PR Newswire)
Mar-04-23 07:11AM	Cardiff Oncology Full Year 2022 Earnings: Beats Expectations (Simply Wall St.)
Mar-02-23 04:10PM	Cardiff Oncology Reports Fourth Quarter and Full Year 2022 Results and Provides Business Update (PR Newswire)
Feb-27-23 08:15AM	Cardiff Oncology to Present at the Cowen 43rd Annual Health Care Conference (PR Newswire)
Feb-02-23 08:00AM	Cardiff Oncology Announces the Appointment of Fairooz Kabbinavar, MD, FACP, as Chief Medical Officer (PR Newswire)
Jan-10-23 08:00AM	Cardiff Oncology to Present at B. Riley Securities' 3rd Annual Oncology Conference (PR Newswire)
Nov-21-22 10:52AM	Cardiff Oncology to Present at Upcoming Investor Conferences (PR Newswire)
Nov-08-22 08:15AM	Cardiff Oncology to Present at the Jefferies London Healthcare Conference (PR Newswire)
Nov-03-22 04:10PM	Cardiff Oncology Reports Third Quarter 2022 Results and Provides Business Updates (PR Newswire)
Sep-12-22 04:05PM	Cardiff Oncology Announces Plans for a Randomized Trial in Metastatic Colorectal Cancer (mCRC), Durability of Responses in Ongoing Phase 1b/2 Trial in mCRC and Additional Business Updates (PR Newswire) +10.69% -41.12%
Sep-10-22 07:30AM	Cardiff Oncology Announces New Preclinical and Clinical Data from Program in KRAS-mutated Metastatic Colorectal Cancer (mCRC) at the ESMO Congress 2022 (PR Newswire)
Sep-08-22 08:15AM	Cardiff Oncology to Present at Upcoming Investor Conferences in September (PR Newswire)
Sep-06-22 08:00AM	Cardiff Oncology Announces Upcoming Poster Presentations at the ESMO Congress 2022 (PR Newswire) -9.25%
Aug-29-22 08:00AM	Cardiff Oncology to Host Webcast and Conference Call to Provide a Clinical and Corporate Update on September 12, 2022 (PR Newswire) -5.73%
Aug-04-22 04:10PM	Cardiff Oncology Reports Second Quarter 2022 Results and Provides Business Updates (PR Newswire) +10.00%
Jul-05-22 08:30AM	Cardiff Oncology to Present at the William Blair Biotech Focus Conference 2022 (PR Newswire) +13.73%
Jul-02-22 09:10AM	Is Cardiff Oncology, Inc. (NASDAQ:CRDF) Popular Amongst Institutions? (Simply Wall St.)
May-17-22 08:30AM	Cardiff Oncology to Present at the H.C. Wainwright Global Investment Conference (PR Newswire) +6.06%
May-09-22 08:02AM	Here's Why We're Not Too Worried About Cardiff Oncology's (NASDAQ:CRDF) Cash Burn Situation (Simply Wall St.) -6.06%
May-05-22 04:10PM	Cardiff Oncology Reports First Quarter 2022 Results and Provides Business Updates (PR Newswire) -6.29%
Apr-12-22 04:00PM	Cardiff Oncology Announces Departure of Chief Medical Officer (PR Newswire)
Apr-08-22 01:05PM	Cardiff Oncology Announces Updated Clinical and New Biomarker Data from Phase 2 Metastatic Castration-Resistant Prostate Cancer Trial at the AACR Annual Meeting (PR Newswire)
01:05PM	Cardiff Oncology Announces Data Showing the Combination of PARP Inhibition with Onvansertib Overcomes PARP Inhibitor Resistance in BRCA1-mutant and Wildtype Patient-Derived Xenograft Ovarian Cancer Models (PR Newswire)
Mar-22-22 09:05AM	Cardiff Oncology to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC (PR Newswire) +7.56%
Mar-17-22 06:32AM	Cardiff Oncology, Inc. (NASDAQ:CRDF) insiders placed bullish bets worth US$681k in the last 12 months (Simply Wall St.) +6.48%
Mar-08-22 04:45PM	Cardiff Oncology Announces Upcoming Poster Presentations at the AACR Annual Meeting (PR Newswire) +7.76%
Mar-01-22 08:30AM	Cardiff Oncology to Participate in Cowen's 42nd Annual Healthcare Conference (PR Newswire)
Feb-24-22 04:10PM	Cardiff Oncology Reports Fourth Quarter and Full Year 2021 Results and Recent Highlights (PR Newswire) +7.49%
Feb-17-22 03:02PM	Cardiff Oncology (CRDF) May Report Negative Earnings: Know the Trend Ahead of Q4 Release (Zacks) -5.79%
Jan-31-22 06:22PM	Cardiff Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (PR Newswire) +6.96%
Jan-20-22 03:44PM	Dont Say Bye Bye to Cardiff Stock, Say Buy Buy: Analyst (TipRanks) -14.95%
01:46PM	Cardiff Oncology to Present at the B. Riley Securities 2022 Oncology Conference (PR Newswire)
Jan-18-22 05:00PM	Cardiff Oncology Announces New Data from Lead Clinical Program in KRAS-mutated Metastatic Colorectal Cancer Showing Robust Objective Response Rate and Progression Free Survival (PR Newswire) -10.50% -25.90%
Jan-13-22 09:17AM	Are Institutions Heavily Invested In Cardiff Oncology, Inc.'s (NASDAQ:CRDF) Shares? (Simply Wall St.)
Jan-11-22 08:00AM	Cardiff Oncology Appoints Tod Smeal, Ph.D., as Chief Scientific Officer and Charles Monahan, RPh, as Senior Vice President, Regulatory Affairs (PR Newswire) +10.18%
Jan-10-22 08:00AM	Cardiff Oncology to Host Conference Call and Webcast to Discuss Updated Data from Lead Clinical Program in KRAS-mutated Metastatic Colorectal Cancer Being Presented at the 2022 American Society of Clinical Oncology Gastrointestinal Cancers Symposium (PR Newswire)
Jan-04-22 08:00AM	Cardiff Oncology to Present at the H.C. Wainwright BioConnect Virtual Conference (PR Newswire)
Dec-28-21 09:38AM	Opaleye Management Inc. Buys Semler Scientific Inc, Keros Therapeutics Inc, Crinetics ... (GuruFocus.com)
Dec-21-21 09:38AM	Opaleye Management Inc. Buys Semler Scientific Inc, Keros Therapeutics Inc, Crinetics ... (GuruFocus.com)
Dec-16-21 09:38AM	Opaleye Management Inc. Buys Semler Scientific Inc, Keros Therapeutics Inc, Crinetics ... (GuruFocus.com)
Dec-10-21 08:30AM	Cardiff Oncology Announces Upcoming Presentation on Lead KRAS-mutated Metastatic Colorectal Cancer Program at the 2022 American Society of Clinical Oncology Gastrointestinal Cancers Symposium (PR Newswire)
Dec-08-21 09:38AM	Opaleye Management Inc. Buys Semler Scientific Inc, Keros Therapeutics Inc, Crinetics ... (GuruFocus.com) +11.07%
Dec-03-21 08:30AM	Cardiff Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (PR Newswire)
Nov-18-21 07:00AM	Cardiff Oncology Announces $15 Million Equity Investment from Pfizer through its Pfizer Breakthrough Growth Initiative (PR Newswire) +18.74%
Nov-14-21 07:18AM	Cardiff Oncology (NASDAQ:CRDF) Is In A Good Position To Deliver On Growth Plans (Simply Wall St.)
Nov-09-21 08:30AM	Cardiff Oncology to Present at Upcoming Jefferies London Healthcare and Piper Sandler 33rd Annual Investor Conferences (PR Newswire)
Nov-04-21 04:15PM	Cardiff Oncology Reports Third Quarter 2021 Results and Provides Business Updates (PR Newswire)
Oct-28-21 03:06PM	Will Cardiff Oncology (CRDF) Report Negative Q3 Earnings? What You Should Know (Zacks)
Sep-30-21 08:36PM	Insider Buying Could Indicate a Bottom in These 2 Stocks (TipRanks) +8.71%
Sep-15-21 06:37AM	James Levine Is The Chief Financial Officer of Cardiff Oncology, Inc. (NASDAQ:CRDF) And Just Spent US$194k On Shares (Simply Wall St.)
Sep-08-21 04:00PM	Cardiff Oncology Announces New Data from Phase 1b/2 Trial in KRAS-mutated Metastatic Colorectal Cancer Showing Robust Objective Response Rate and Progression Free Survival (PR Newswire)
Sep-07-21 08:30AM	Cardiff Oncology to Present at Upcoming Investor Conferences in September (PR Newswire)
Aug-25-21 08:15AM	Cardiff Oncology to Present New Data from Lead Clinical Program in KRAS-mutated Metastatic Colorectal Cancer on September 8, 2021 (PR Newswire) +9.18%
Aug-06-21 04:15AM	How Many Cardiff Oncology, Inc. (NASDAQ:CRDF) Shares Do Institutions Own? (Simply Wall St.) +11.84%
Aug-05-21 04:15PM	Cardiff Oncology Reports Second Quarter 2021 Results and Provides Business Updates (PR Newswire)

Cardiff Oncology, Inc. is an oncology therapeutics company, which engages in the development of drugs that target mitosis for the treatment of various types of cancer. It is focused on developing onvansertib, a first-in-class, third-generation Polo-like Kinase 1 (PLK1) inhibitor, in combination with standard-of-care chemotherapy and targeted therapeutics. The firm's clinical programs include KRAS-Mutated Metastatic Colorectal Cancer (mCRC), Resistant Metastatic Castration-Resistant Prostate Cancer (mCRPC) and relapsed or refractory Acute Myeloid Leukemia (AML). The company was founded by Gabriel M. Cerrone, L. David Tomei, Samuil Umansky, and Hovsep Melkonyan in 1999 and is headquartered in San Diego, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
PACE GARY W	Director	Dec 19 '23	Buy	1.37	30,000	41,100	697,761	Dec 19 06:39 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

CRDF

Cardiff Oncology Inc

Upgrade your FINVIZ experience